- Forums
- ASX - By Stock
- CTT
- Ann: Cettire Upgrades FY21 Prospectus forecasts
Ann: Cettire Upgrades FY21 Prospectus forecasts, page-41
-
- There are more pages in this discussion • 386 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CTT (ASX) to my watchlist
|
|||||
Last
$1.39 |
Change
0.000(0.00%) |
Mkt cap ! $528.0M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 24453 | $1.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.29 | 2462 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3415 | 1.470 |
3 | 9453 | 1.405 |
2 | 107500 | 1.400 |
1 | 2000 | 1.390 |
1 | 5400 | 1.385 |
Price($) | Vol. | No. |
---|---|---|
1.285 | 2462 | 1 |
1.360 | 203 | 2 |
1.375 | 2169 | 1 |
1.380 | 71 | 1 |
1.385 | 192 | 1 |
Last trade - 10.00am 16/07/2024 (20 minute delay) ? |
Featured News
CTT (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online